CRISPR-Based Knock-In for Cell Lineage Tracing in Esophageal Organoids Revealed by Researchers at University of Texas MD Anderson Cancer Center

Researchers at the University of Texas MD Anderson Cancer Center have made significant strides in understanding the biology of epithelial lineage hierarchies and cancer through the development of a new approach to gene manipulation in esophageal organoids. By utilizing CRISPR-Cas9-based knock-in (KI) methods, scientists can now precisely tag cell lineage and track growth dynamics and differentiation trajectories in real-time. This breakthrough has far-reaching implications for cancer modeling and damage-response studies.

Key Takeaways:

• Researchers at the University of Texas MD Anderson Cancer Center have developed a novel CRISPR-Cas9-based knock-in approach for gene manipulation in esophageal organoids.
• This method allows for precise cell lineage tracing and live imaging, enabling researchers to monitor growth dynamics and differentiation trajectories in real-time.
• The CRISPR-Cas9 design, donor construction using homology-independent approaches (CRISPaint), delivery into organoid cells, enrichment, and single-clone isolation are outlined in the protocol.
• The research highlights the practical advantages of non-homologous end joining (NHEJ)-based methods for robust, frame-accurate KI with minimal cloning.
• The methods outlined in the research can be applied broadly for cell lineage tracing, damage-response studies, and cancer modeling.
• Kyung-Pil Ko and colleagues developed and validated the protocol, demonstrating its effectiveness in generating fluorescent KI organoids from murine esophageal epithelium.

Statistics:

• The research utilized CRISPR-Cas9-based knock-in approaches to manipulate gene expression in esophageal organoids.
• The protocol involved tagging Krt13 (BFP) and Sox2 (mNeon) using homology-independent approaches (CRISPaint).
• The researchers highlighted the practical advantages of NHEJ-based methods, which enabled robust, frame-accurate KI with minimal cloning.
• The methods outlined in the research have the potential to be applied broadly for cell lineage tracing, damage-response studies, and cancer modeling.

Sources:

• Genetic Engineering of Esophageal Organoids: CRISPR-Based Knock-In for Cell Lineage Tracing. Methods In Molecular Biology, 2025.
• NewsRx. Data on Cancer Research Described by Researchers at University of Texas MD Anderson Cancer Center (Genetic Engineering of Esophageal Organoids: CRISPR-Based Knock-In for Cell Lineage Tracing). Cancer Weekly. October 21, 2025; p 992.